MoneyWorks4Me

Vasundhara Rasayans - Quaterly Results

12 Feb 2024 Evaluate
A minor change in the total revenue was seen in the December 2023 quarter. The total revenue for the quarter stood at Rs. 82.27 millions against Rs. 81.10 millions during year ago period.The Net Profit of the company registered a slight decline of -19.83% to Rs. 13.83  millions from Rs. 17.25 millions.The company reported a degrowth in operating Profit to 19.55 millions from 23.58 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 82.27 81.10 1.44 258.80 280.28 -7.66 379.41 267.50 41.84
Other Income 5.02 3.81 31.76 11.97 21.32 -43.86 22.98 10.44 120.11
PBIDT 19.55 23.58 -17.09 53.19 70.70 -24.77 78.06 32.06 143.48
Interest 0.09 0.00 0.00 1.00 0.00 0.00 2.00 0.44 354.55
PBDT 19.46 23.58 -17.47 52.19 70.70 -26.18 76.06 31.62 140.54
Depreciation 0.78 0.27 188.89 1.83 0.94 94.68 1.31 1.15 13.91
PBT 18.68 23.31 -19.86 50.36 69.76 -27.81 74.75 30.47 145.32
TAX 4.85 6.06 -19.97 13.09 18.14 -27.84 18.85 8.66 117.67
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.02 0.05 -140.00
PAT 13.83 17.25 -19.83 37.27 51.62 -27.80 55.90 21.81 156.30
Equity 31.78 31.78 0.00 31.78 31.78 0.00 31.78 31.78 0.00
PBIDTM(%) 23.76 29.08 -18.27 20.55 25.22 -18.52 20.57 11.99 71.66
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..